Related Experiment Video
Updated: May 25, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device
Insights
The Hepcon/HMS device improved anticoagulation management during cardiac surgery, reducing bleeding and red blood cell transfusions. This method offers a safer approach to heparin and protamine titration, leading to shorter chest closure times.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Hematology
Background:
- Standard anticoagulation protocols using unfractionated heparin (UH) require careful management during cardiopulmonary bypass (CPB).
- Accurate titration of heparin and protamine is crucial to prevent bleeding and thromboembolic complications in cardiac surgery patients.
Purpose of the Study:
- To compare the efficacy of the standard anticoagulation protocol versus the Hepcon/HMS device for heparin and protamine management.
- To evaluate the impact of the Hepcon/HMS device on postoperative bleeding, transfusion requirements, and procedural times.
Main Methods:
- A comparative study involving 44 patients undergoing coronary artery bypass grafting (CABG) or aortic valve replacement (AVR).
- Patients were divided into two groups: a control group (n=22) receiving standard UH anticoagulation and a Hepcon/HMS group (n=22) where doses were guided by the device.
- Protamine was used to antagonize heparin in a dose-dependent manner in both groups.
Main Results:
- The Hepcon/HMS group exhibited significantly shorter chest closure times (42 ± 15 min vs. 68 ± 27 min, p=0.001).
- Postoperative bleeding was significantly lower in the Hepcon/HMS group (804 ± 729 ml vs. 1416 ± 1103 ml, p=0.016).
- Red blood cell transfusion requirements were reduced postoperatively in the Hepcon/HMS group (1.04 ± 1.5 units vs. 2.1 ± 1.87 units, p=0.05).
Conclusions:
- Heparin and protamine titration using the Hepcon/HMS device during CPB can lead to reduced protamine dosage and lower postoperative bleeding.
- The Hepcon/HMS system may decrease perioperative red blood cell transfusions and shorten chest closure times without increasing thromboembolic events.
Objective:
The objective of our study was to compare the standard protocol of anticoagulation to the Hepcon/HMS.
Method:
This study included forty-four patients who underwent coronary bypass grafting surgery (CABG), or biological aortic valve replacement (AVR). Unfractionated heparin (UH) was used for patients who underwent operations in the control group (n = 22) (300U/Kg of UH with a goal of an ACT of 400s). The heparin was antagonized dose/dose by protamine. For the patients who underwent operations in the HMS group (n = 22), the heparin and protamine doses were assessed by the Hepcon/HMS device.
Results:
The sex ratio amounted to 1.93 (29 men and 15 women) and the mean age was 70 ± 11 years. The patients in the HMS group had a chest closure time that was significantly shorter than patients in the control group. The times were, respectively, 42 ± 15 minutes and 68 ± 27 minutes (p = 0.001). The protamine/heparin ratio was significantly lower in the HMS group (0.62 ± 0.13 vs. 1 ± 0.11) (p = 0.0001). The postoperative bleeding amounted to 804 ± 729 ml in the HMS group versus 1416 ± 1103 in the control group (p = 0.016). In multivariate linear regression analysis, only two independent factors were significantly associated with bleeding: the Hepcon/HMS (OR = 0.1-p = 0.03) and the preoperative hemoglobin rate (OR = 1.4 - p = 0.05). Postoperatively, within 72 hours, the red blood cell transfusion was 1.04 ± 1.5 units for the HMS group and 2.1 ± 1.87 units for the control group (p = 0.05).
Conclusion:
During cardiac surgery under CPB, heparin and protamine titration with the Hepcon/HMS device could predict a lower protamine dose and lower postoperative bleeding without higher thromboembolic events, and lower perioperative red blood cell transfusion with a shorter chest closure time.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Holter Monitor: 24-Hour Monitoring
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications

